Ion Channel Genes in Painful Neuropathies

被引:6
|
作者
Sleczkowska, Milena [1 ,2 ]
Misra, Kaalindi [3 ]
Santoro, Silvia [3 ]
Gerrits, Monique M. [4 ]
Hoeijmakers, Janneke G. J. [2 ]
机构
[1] Maastricht Univ, Dept Toxicogen, NL-6229 ER Maastricht, Netherlands
[2] Maastricht Univ, Sch Mental Hlth & Neurosci, Med Ctr, Dept Neurol, NL-6229 ER Maastricht, Netherlands
[3] IRCCS San Raffaele Sci Inst, Lab Human Genet Neurol Disorders, INSPE, I-20132 Milan, Italy
[4] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 HX Maastricht, Netherlands
关键词
neuropathic pain; ion channel genes; neuropathy; variants; pathophysiology; channelopathies; ACTIVATED PACEMAKER CHANNELS; GATED SODIUM-CHANNELS; DORSAL-ROOT GANGLION; RAT SENSORY NEURONS; MICE LACKING; ANOCTAMIN; CALCIUM-CHANNELS; UP-REGULATION; TRPV1; HEAT;
D O I
10.3390/biomedicines11102680
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuropathic pain (NP) is a typical symptom of peripheral nerve disorders, including painful neuropathy. The biological mechanisms that control ion channels are important for many cell activities and are also therapeutic targets. Disruption of the cellular mechanisms that govern ion channel activity can contribute to pain pathophysiology. The voltage-gated sodium channel (VGSC) is the most researched ion channel in terms of NP; however, VGSC impairment is detected in only <20% of painful neuropathy patients. Here, we discuss the potential role of the other peripheral ion channels involved in sensory signaling (transient receptor potential cation channels), neuronal excitation regulation (potassium channels), involuntary action potential generation (hyperpolarization-activated cyclic nucleotide-gated channels), thermal pain (anoctamins), pH modulation (acid sensing ion channels), and neurotransmitter release (calcium channels) related to pain and their prospective role as therapeutic targets for painful neuropathy.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] Electroacupuncture Is Not Effective in Chronic Painful Neuropathies
    Penza, Paola
    Bricchi, Monica
    Scola, Amalia
    Campanella, Angela
    Lauria, Giuseppe
    PAIN MEDICINE, 2011, 12 (12) : 1819 - 1823
  • [22] Oxcarbazepine in Treatment of Painful Peripheral Neuropathies
    Rogin, Joanne B.
    EPILEPSY & BEHAVIOR, 2000, 1 (06) : 454 - 454
  • [23] Status of immune mediators in painful neuropathies
    Nurcan Üçeyler
    Claudia Sommer
    Current Pain and Headache Reports, 2008, 12
  • [24] Painful and Painless Diabetic Neuropathies: What Is the Difference?
    Shillo, Pallai
    Sloan, Gordon
    Greig, Marni
    Hunt, Leanne
    Selvarajah, Dinesh
    Elliott, Jackie
    Gandhi, Rajiv
    Wilkinson, Iain D.
    Tesfaye, Solomon
    CURRENT DIABETES REPORTS, 2019, 19 (06)
  • [25] Differential expression of cytokines in painful and painless neuropathies
    Uceyler, Nurcan
    Rogausch, Jan P.
    Toyka, Klaus V.
    Sommer, Claudia
    NEUROLOGY, 2007, 69 (01) : 42 - 49
  • [26] EXPERIMENTAL-MODELS OF PAINFUL PERIPHERAL NEUROPATHIES
    BENNETT, GJ
    NEWS IN PHYSIOLOGICAL SCIENCES, 1990, 5 : 128 - 133
  • [27] Painful neuropathies: the emerging role of sodium channelopathies
    Brouwer, Brigitte A.
    Merkies, Ingemar S. J.
    Gerrits, Monique M.
    Waxman, Stephen G.
    Hoeijmakers, Janneke G. J.
    Faber, Catharina G.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2014, 19 (02) : 53 - 65
  • [28] Focal Painful Neuropathies Treated with Rimabotulinumtoxin B
    Grogan, Patrick
    Alvarez, Maria
    Chao, Wendy
    NEUROLOGY, 2013, 80
  • [29] Painful and Painless Diabetic Neuropathies: What Is the Difference?
    Pallai Shillo
    Gordon Sloan
    Marni Greig
    Leanne Hunt
    Dinesh Selvarajah
    Jackie Elliott
    Rajiv Gandhi
    Iain D. Wilkinson
    Solomon Tesfaye
    Current Diabetes Reports, 2019, 19
  • [30] Potential limitations and risks in the treatment of painful neuropathies
    Penkert, G
    SCHMERZ, 2000, 14 (04): : 240 - 244